Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-004796
Filing Date
2021-02-03
Accepted
2021-02-03 20:03:52
Documents
2
Period of Report
2021-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1571
2 EX-24 DOCUMENT attachment1.htm EX-24 3675
  Complete submission text file 0000899243-21-004796.txt   6630
Mailing Address AVEO PHARMACEUTICALS, INC. 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Cole Douglas G. (Reporting) CIK: 0001486373 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39941 | Film No.: 21588257

Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Issuer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)